Natco gets CDSCO nod for emergency use of Baricitinib tablets for COVID-19 treatment
Home Health Natco gets CDSCO nod for emergency use of Baricitinib tablets for COVID-19 treatment
Health - 2 weeks ago

Natco gets CDSCO nod for emergency use of Baricitinib tablets for COVID-19 treatment

Baricitinib in combination with Remdesivir, is used for treatment of COVID-19 positive patients, the Natco Pharma said

Drugmaker Natco Pharma has received emergency use approval for Baricitinib tablets, 1 mg, 2 mg and 4 mg strengths, from Central Drugs Standard Control Organisation (CDSCO) in India. 

Baricitinib, in combination with Remdesivir, is used for treatment of COVID-19 positive patients, a release from Natco on the approval said. 

The company said it intends seeking a compulsory license based on emergency use and in light of the grave and serious public health emergency across India due to the pandemic. It is ready to launch the product this week, so as to make it available to the patients across India, the release said. 


Source link

Leave a Comment

Check Also

“We are working on getting 100 hospital beds and over 500 oxygen concentrators,” says Jacqueline Fernandez amid COVID crisis in India : Bollywood News – Bollywood Hungama

Jacqueline Fernandez’s recently launched foundation YOLO is working endlessly to hel…